Dáil Éireann Debate, Wednesday - 15 November 2023
148. Deputy Rose Conway-Walsh asked the Minister for Health for an update regarding the appointment of an independent chairperson to the sodium valproate inquiry; the reason why a chairperson has not been appointed to date; when he expects the chairperson to be in place and for the inquiry to begin; and if he will make a statement on the matter. [50139/23]
View answerWhen I met with the patient groups involved with this issue, I supported their call for an inquiry into sodium valproate and I committed to making that happen. I was delighted to secure Government approval for the establishment of an inquiry which will examine the licensing and use of sodium valproate in women of child-bearing potential in the State. I am very pleased to be able to progress this. This inquiry will be designed to give a voice to patients and their families while looking at the use of sodium valproate in Ireland since it was first licensed.
Work is actively ongoing in my Department in relation to sourcing an appropriate person to Chair the inquiry, and the Deputy will appreciate that this is a sensitive matter. The Chair is an essential role that needs careful consideration. The role requires and experienced person who will run a fair and independent process, and who can give the inquiry the time and attention it deserves.
There is more work to be done to establish the inquiry It is important that enough time and resources are invested in completing this work. There are many factors to consider, and I want to ensure that the inquiry established delivers and allows those impacted to tell their story and my officials are working to ensure that this will be facilitated.
I will be glad to provide an update on this matter once this work is finalised.
